The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Please help me to understand the connections. Are the 3 companies working independently on competing products? Or are they working together? I hold both Avacta and Skin.
I've been out of it for 24 hours so please forgive me if this is old news.
The Yorkshire Post says Aptamer, a partner of SKIN, « is just a couple of weeks away from having a prototype device ready and “around a month away” from having a design ready for manufacture.»
Sorry I missed s lot of yesterday's discussions. I was getting a vaccination. Slept most of the time since. Just having breakfast.
The missing part is a plan of how we get this to market and money in the bank. Huge potential.
I think the Board were not expecting much interest from new shareholders so they pitched it to guys who didn't need to hear it all. Last year the company was a tiny. The directors left home in charge of a team in the Southern League but walked into an AGM of Championship team. Maybe not the best analogy but I've just got out of bed. It's Sunday.
The evidence suggests that Helium made 2 trades on Thursday.
One was 2.5m and the other 2.7m.
Presumably with different MMs.
It still holds 3.7m SKIN shares.
I think it also holds 5% of MWG.
It has a policy of not investing in businesses with MC over 50m. Do the math. They had to sell if the price went up. We were 40% of the Helium portfolio on Wednesday. The sales on Thurday reduced that to 30%
We have no idea what Helium did on Friday.
Now put yourself in the position of the MM.
If Helium had sold slowly over a period of weeks instead of dumping this crisis may have been avoided.
A Swiss friend told me that the investment house which Helium is part of, ISP in Switzerland, is well known for coaching young inexperienced fund managers. Maybe, just maybe, the manager of Helium hadn't thought this through clearly.
Bought on a dip with the intention of holding for many years. This looks like the strongest European fund. Good stock picking produces Alpha. That's rare.
Almost every stock is the best at what it does. Quality businesses which will grow. Many are global household names. Some dominate their markets. I had intended to buy several of the holdings myself as I think they will do very well in years to come. The Fund Manager has a great reputation and BlackRock hire quality people. This is a good home for a chunk of my portfolio.
I just found these posts made by Gerry Brandon last night. Maybe you missed them as well:-
Guys I can't read or answer over 700 comments. But I can post what has been posted elsewhere in answer to questions in the AGM today.
The breathalyser is personal, to you. It will cost in the region of $25 or £20. That is yours and is multi-use.
You use a Microtox BT chip for each test. These tests will be available in a similar way to how you buy Gillette Fusion Blades in packs of five/ten. Each test will cost £4 or $5. These are the daily tests.
It is intended as part of the project to place readers across the country in train stations, petrol stations, shopping malls, office buildings, theatres, cinemas, hotel lobbies. Consider them equivalent to Vending Machines. These are funded using securitised means based on future recurring revenues.
These readers are free to use. No reader is required to be purchased so long as there is a large footfall in the vicinity of the reader.
Businesses, however, may purchase their own. Business who do so will be subsidised and there is a tax advantage in purchasing in companies for Health and safety reasons.
Each chip has its own security code using highly secure blockchain to verify a) that it is genuine (not capable of being copied with fakes) and b) so that it can be identified on the Microtox BT servers. A fake chip will not be scanned.
Once the scan (in the reader) is done it takes seconds to get a result. This is sent over the air (OTA) to your mobile phone (Microtox BT App) and stored in your results folder. This is unique to you because it combines registration of your device to the verified code on the microchip test.
Now the result is valid for 24 hours.
In other words, for the next 24 hours, anyone can use any free QR Code app, that you can download from any app-store, to scan your QR Code in your Microtox BT app which will compare it on our servers for proof that it matches the test taken at any reader anywhere in the last 24 hours that you are negative.
Just one point to clarify. Wastewater is first out the door. We only change 3 things on the Modern Water OVA7100 units already installed.
We replace the voltometer with a laser canning unit
We increase the filtration by adding a 10 micron (off the shelf) filter to the 100 micron already in place, and
We use the motorised arm to exchange microchips instead of changing the reagents.
Everything else is the same. These will be rolled out in early Q1 with no regulatory hurdles to be met, just samples from testing on the actual virus for our dataset to compare with the digital signal analysed using AI
That is already to go
Can someone remind me of the CitySprint story please. DNE still holds 5% but it has been valued at zero.
I don't see why a zero value would be appropriate unless it draining cash.
The delivery business faces practical covid issues but it appears to be working close to capacity and I guess it's profitable?
BeachHut - You put quotation marks around my paragraph making it appear as if I wrote that the FT had named OO. My quotation marks were round 9 words in the middle of the paragraph. Please be more careful when quoting. We're better than journalists.
I note that Barwickman found nVivo mentioned in the Daily Fail.
New Day. New Challenges.
Hi Jack. The UK Press Core wouldn't be slow to produce headlines about UK Gov handing huge contracts to any business which is paying that cash out as dividends or enormous salaries. Give they guys a break.
We might get the delayed dividend in the form of a special divi or it may be spread over a period. Half term results are coming up soon. A wee bit of divi would be nice but not if it means that the business looses a contract.
Ho Cautious. Really good to read your comments. Thanks.
I ran your comments past a mathematician who happened to be in the room. He tried to reduce what you said to simplistic stuff for me. He tells me that you suggest that if it could detect 1k particles/ml the device could be effective, but you suggest that they are not clear whether the device is that sensitive? A second point is that hey are hoping that AI/ML will allow improvement in the accuracy/sensitivity of the device?
My tame maths guy isn't into medicine but he is aware of fairly new branches of maths, loosely developments of Bayes, which are being used in AI and which might be used to improve accuracy. This stuff is so new there will be few people out there who know it well. However the maths used in medical stats is also based on Bayes so it's possible that they have a good sharp statistician who saw the application. They would earn Brownie points from me if they have recruited guys that good.
The really interesting trade was after the day ended.
16.43 156,500@ 58 p - so what price the open?
27.68% of SKIN shares were traded today per LondonStockExchange.com 31,278,330 / 113m
My feed from LSE for this share, but others, stopped at 15.30. I picked up the following from ADVFN
2.65m share morning purchases were delayed.
10.19 1,500,000 at 64.52 BUY
10.41 400,000 at 60.55 BUY
10.47 250,000 at 61.05 BUY
12.08 500,000 at 61.51 BUY
16.43 156,500 at 58.00 BUY - this trade appears to have been after hours? at a price above the spread
No delayed trades as at 17.15. Surprised.
Price falls 19.8% after
Vol. Sold 7,187,902
Vol. Bought 13,698,685
Does this make sense to anyone ?
Looking past the amateurish presentation skills the product has a huge market although it isn't for home use.
At £3-£4 per test it's the price of a latte and that's doable with chip readers at transport hubs, offices and places of employment. Shops like Robert Dyas and Ryman and supermarkets may have readers available for public use at a nominal fee.
This is a test which costs very little and will enable us to get back to something like normal.
After paying £80 for a ticket to see the Arsenal and £5 for a pint of beer inside whats £3-£4 to prove that you are clear of Covid for 24 hours? Huge potential.
I was in before this news broke and I have doubled my holding now that I understand the product.
Proven technology much of it already in use for other purposes.
The business was strong and getting stronger last week. This is all good news with revenue potential within 6 months.
Me too ... holding ORPH and SKIN and holding tight on the roller coasters.
I also hold DNL which presented with ORPH last week. It is less of a roller coaster. More of a hill we are gradually climbing towards FDA approval which is scheduled for 29th Sept. Not raising the heart rate in the way that ORPH and SKIN have done but rising nicely with a few days to run.
The RNS should gave been out yesterday. All CF has done is give the market some much needed information and guidance. Whilst other firms say nothing and only tell institutional investors what is happening, OO has attempted to be fair to us, the wee guys. The fault, if any, is the delay in issuing guidance.
I'm guessing that the FT got the story from Whitehall and surprised CF.
I don't recall any report which mentions ORPH by name so only clued up investors and pros will know that ORPH is name to look for. At some point, most likely next week at the official announcement, the company name might be revealed. However there may be some confidentiality gig which prevents the business capitalising on the publicity. Such restraint would probably be painful for both CF and BoJo but some mandarin down Whitehall may have spotted the banana skin waiting for his boss who would luv to describe this as an example of fantastic British enterprise. Dublin would not be amused. The Dublin press follows the exploits of CF in the same way that the Daily Planet follows Superman. They are most likely to use the company name since that's their hook for the story.
Made a judgement that there will be much more to come. Added 25% to my holding just before market closed. Paid a higher price than we have seen but all the evidence suggests it will soon look cheap.
1. The news was not widely known before 4.30. It wasn't on CNBC and the Daily Mail until 4.25 or later. As far as I can see only the FT had it earlier. If mentioned on Bloomberg I missed it.
2. The wearables business has yet to be monetized. I'm expecting a royalty based contract with a huge DCF value. A sale of our db would be a huge mistake. It's got to be worth much more on a licence.
3. Official announcement of today's news next week.
4. The second, larger, facility for the Challenge could multiply revenue.